Delivery Order SPE2DB22D3501-SPE2DB24FVU70
Award Date
5/29/24
Potential Completion Date
6/20/24
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of ANDEXXA 200 MG VIALS, a pharmaceutical product, with a ceiling value of $19,734.84 and a period of performance through March 15, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply ANDEXXA 200 MG VIALS. The contract has a ceiling value of $25,174.65 and a period of performance through May 3, 2024. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a wholly-owned subsidiary of Amerisourcebergen Corporation. The contract, valued at $7,570.17, is for the supply of ANDEXXA 200 MG VIALS, a specialty pharmaceutical product. This delivery order is issued under an indefinite delivery contract (IDC) with a total potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation. The contract is for the delivery of ANDEXXA 200 MG VIALS, a medical product. The contract has a ceiling value of $13,317.44 and a completion date of October 11, 2024. The contract is a Firm Fixed Price (FFP) arrangement, with no set-aside designation. AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, is the prime contractor for this delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $79,161.66 firm fixed-price delivery order is for the supply of ANDEXXA 200 MG VIALS. The contract has an ultimate completion date of November 18, 2022 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ANDEXXA 200 MG VIALS, a medical product, with a ceiling value of $6,931.53 and a period of performance through April 11, 2025. The contract is not designated as a set-aside, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
The U.S. government has awarded a delivery order contract worth $15,050.28 to Amerisourcebergen Drug Corp's Corporate Office Division to provide the pharmaceutical product ANDEXXA 200 MG VIALS. This contract has no set-aside designation and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen supplies a comprehensive range of...
The Defense Logistics Agency Troop Support Medical awarded a $24,905.91 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 milligram vials of ANDEXXA. The prime contractor, Amerisourcebergen Drug Corporation, will deliver the pharmaceutical products from its facility located in Conshohocken, Pennsylvania. The delivery order was awarded under an indefinite-delivery/indefinite-quantity contract vehicle and has a period of performance spanning from August 14, 2023 to...
This is a $34,780.89 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which runs through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and...
This is a delivery order award by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award has a firm fixed price of $1,033.50 and a completion date of December 24, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC provides a comprehensive range of...